Sarcoidosis is a granulomatous disorder that can affect multiple organs. The lungs are affected most often (in 9 out of 10 cases in the UK). It is a noncaseating, restrictive lung disease.
| Sarcoidosis | |
|---|---|
| Other names | Sarcoïdosis, sarcoid, Besnier–Boeck–Schaumann disease |
| Chest X-ray showing the typical nodularity of sarcoidosis, predominantly in the hila of the lungs. | |
| Pronunciation |
|
| Medical specialty | Rheumatology, Immunology |
| Symptoms |
|
| Usual onset | 20–50 years old More common in women |
| Duration | Few years to long term |
| Causes | Unknown |
| Risk factors | Family history |
| Diagnostic method | Based on symptoms and tissue biopsy |
| Differential diagnosis | Tuberculosis, lymphoma, infectious mononucleosis, pulmonary eosinophilia |
| Treatment | Ibuprofen, prednisone, methotrexate |
| Prognosis | Mortality 1–7% |
| Frequency | 1.9 million with interstitial lung disease (2015) |
| Deaths | 122,000 with interstitial lung disease (2015) |
The cause is not known. Corticosteroids such as prednisone are often used to treat sarcoidosis. In some cases, methotrexate may be also used. Antimalarial drugs have also been used.
Sarcoidosis may involve the brain. If it does, it is called neurosarcoidosis. In some cases, pulmonary fibrosis is a complication of sarcoidosis.